← FDA DRUG APPROVALS

FDA ANDA · ANDA088377

PROPANTHELINE BROMIDE

Sponsor: PAR PHARM

APPLICATION
ANDA088377
TYPE
ANDA
ORIGINAL APPROVAL
1993-10-25
LATEST ACTION
1993-10-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPANTHELINE BROMIDEDiscontinued
PROPANTHELINE BROMIDE 15MG · TABLET · ORAL

Approval history

1993-10-25OriginalAP
1991-03-20Labeling · Supplement 14AP
1988-08-29Labeling · Supplement 11AP
1988-06-16Labeling · Supplement 10AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →